Concepedia

Jia Wang

JW

Statistics

Publications

2

Citations

66

H-Index

2

Active since

2020

Affiliations

Tianjin Medical University(Current)

Tianjin First Center Hospital

Shanghai CASB Biotechnology (China)

Jia Wang is an author at Tianjin Medical University specializing in oncology, chimeric antigen receptor t-cell therapy, and hematologic malignancy therapy.

ORCID

Publications per year

2020–2022

2

Publications

2

Efficacy and safety of humanized anti‐CD19‐CAR‐T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia

Jia Wang, Nan Mou, Zhenxing Yang et al. · British Journal of Haematology · 2020 · 52 citations · Full text

, , +17

Efficacy of programmed cell death 1 inhibitor maintenance therapy after combined treatment with programmed cell death 1 inhibitors and anti‐CD19‐chimeric antigen receptor T cells in patients with relapsed/refractory diffuse large B‐cell lymphoma and high tumor burden

Juan Mu, Haobin Deng, Cuicui Lyu et al. · Hematological Oncology · 2022 · 14 citations

, , +17

1–2 of 2